
Daewoong Pharmaceutical Continues Growth with ‘Nabota’ and 'Fexuclu’
Daewoong Pharmaceutical is expected to sustain its growth this year, driven by its new drugs “Nabota” and “Fexuclu.” The company achieved record-high revenue and operating profit last year, fueled by the strong performance of its core products, including …